LivingGLP1
Study S000758

Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients

Registration

Registration
NCT03671733
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE3
Masking
NONE
Status
UNKNOWN
Enrollment
150
Start
2018-09-01
Primary completion
2022-09-01
Lead sponsor
Xiangya Hospital of Central South University
Conditions
Obesity
Interventions
DRUG:Liraglutide; DRUG:Exenatide; DRUG:Exenatide Microspheres for Injection
Results posted
FALSE

Registered primary outcomes

  • Weight Change at 3 months [baseline , 3 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.